Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever

Journal of Infectious Diseases

Volumn 180, Issue 5, 1999, Pages 1429-1435

  Green, Sharone ^a   Pichyangkul, Sathit ^b   Vaughn, David W ^b,d   Kalayanarooj, Siripen ^c   Nimmannitya, Suchitra ^c   Nisalak, Ananda ^b   Kurane, Ichiro ^a,e   Rothman, Alan L ^a   Ennis, Francis A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^c Queen Sirikit National Institute for Child Health   (Thailand)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN;

ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; BLOOD ANALYSIS; CYTOKINE PRODUCTION; DENGUE; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PERIPHERAL LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THAILAND;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD8-POSITIVE T-LYMPHOCYTES; CHILD; DENGUE; DENGUE HEMORRHAGIC FEVER; FEMALE; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; T-LYMPHOCYTE SUBSETS;

EID: 0032754317     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315072     Document Type: Article

References (40)

1. 1. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue hemorrhagic fever. Lancet 1998;352:971-7.
2. 2. Halstead SB. Dengue haemorrhagic fever a public health problem and a field for research. Bull World Health Organ 1980;58:1-21.
3. 3. Sangkawibha N, Rojanasuphot S, Ahandrik S, et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 1984;120:653-69.
4. 4. Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988;38:172-80.
5. 5. Kurane I, Rothman AL, Livingston PG, et al. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl 1994;9:59-64.
6. 6. Kurane I, Innis BL, Nimmannitya S, et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and inierferon-γ in sera of children with dengue. J Clin Invest 1991;88:1473-80.
7. 7. Green S, Vaughn DW, Kalayanarooj S, et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999;179:755-62.
8. +CD8 cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J Virol 1991;65:1823-8.
9. + T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type-1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination. J Virol 1993;67:5962-7.
10. 10. Livingston PG, Kurane I, Dai LC, et al. Dengue virus-specific, HLA-B35-restricted, human CD8(') cytotoxic T lymphocyte (CTL) clones-recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J Immunol 1995;154:1287-95.
11. 11. Mathew A, Rurane I, Green S, et al. Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection. J Virol 1998;72:3999-4004.
12. 12. Hara T, Jung LKL, Bjorndahl JM, Fu SM. Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32kD disulfide-linked early activation antigen (EA-1) by 12-o-tetradecanoyl phorbol-12-acetate, mitogens, and anligens. J Exp Med 1986;164:1988-2005.
13. 13. Testi R, Phillips JH, Lanier LL. T cell activation via leu-23 (CD69). J Immunol 1989;143:1123-8.
14. 14. Lanier LL, Buck DW, Rhodes L, et al. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the leu23 activation antigen. J Fxp Med 1988;167:1572-85.
15. 15. De Maria R, Cifone MG, Trotta R, et al. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 1994;180:1999-2004.
16. 16. Maino VC, Suni MA, Ruitenberg JJ. Rapid flow cytometric method for measuring lymphocyte subset activation, Cytometry 1995;20:127-33.
17. 17. Prince HE, Lape-Nixon M. CD69 expression reliably predicts the anti CD3-induced proliferative response of lymphocytes from human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol 1997;4: 217-22.
18. 18. Kalayanarooj S, Vaughn DW, Nimmannitya S, et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997;176: 313-21.
19. 19. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 1997;176:322-30.
20. 20. Dengue haemorrhagic fever: diagnosis, treatment and control. Geneva: World Health Organization, 1986.
21. 21. Innis BL, Nisalak A, Nimmannitya S, et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 1989;40:418-27.
22. 22. Clarke DH, Casals J, Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958; 7:561-73.
23. 23. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30:545-51.
24. 24. Thein S, Aung MM, Shwe TN, et al. Risk factors in dengue shock syndrome. Am J Trop Med Hyg 1997;56:566-72.
25. 25. Fujimoto J, Levy S, Levy R. Spontaneous release of the leu-2 (T8) molecule from human T cells. J Exp Med 1983;158:752-66.
26. 26. Rubin LA, Kurman CC, Fritz ME, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985;135:3172-7.
27. 27. Tomkinson BE, Brown MC, Ip SH, Carrabis S, Sullivan JL. Soluble CD8 during T cell activation. J Immunol 1989;142:2230-6.
28. 28. Trinchieri G, Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 1985;6:131-6.
29. 29. Sung SSJ, Bjorndahl JM, Wing CY, Kao HT, Fu SM. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J Exp Med 1988;167:937-53.
30. 30. Bemelmans MHA, Abramowicz D, Gouma DJ, Goldman M, Buurman WA. In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. J Immunol 1994;153:499-506.
31. 31. Boismenu R, Havran WL. An innate view of γδ T cells. Curr Opin Immunol 1997;9:57-63.
32. 32. Nelson ER, Bierman HR, Chulajata R. Hematologic findings in the 1960 hemorrhagic fever epidemic (dengue) in Thailand. Am J Trop Med Hyg 1964;13:642-9.
33. 33. Boonpucknavig S, Lohachitranond C, Nimmannitya S. The pattern and nature of the lymphocyte population response in dengue hemorrhagic fever. Am J Trop Med Hyg 1979;28:885-9.
34. 34. Wells RA, Scott RM, Pavanand K, Sathitsathein V, Cheamudon U, MacDermott RP. Kinetics of peripheral Wood leukocyte alterations in Thai children with dengue hemorrhagic fever. Infect Immun 1980;28:428-33.
35. 35. Homchampa P, Sarasombath S, Suvatte V, Vongskul M. Natural killer cells in dengue hemorrhagic fever/dengue shock syndrome. Asian Pac J Allergy Immunol 1988;6:95-102.
36. + T cells in the liver during the control and resolution phases of influenza pneumonia. Proc Natl Acad Sci USA 1998;95:13812-7.
37. 37. Cornain S, Ikeuchi H, Sumarmo. Immunological changes and recovery in patients with dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1987;18:340-5.
38. 38. Sarasombath S, Suvatte V, Homchampa P. Kinetics of lymphocyte subpopulations in dengue hemorrhagic fever/dengue shock syndrome. Southeast Asian J Trop Med Public Health 1988;19:649-56.
39. 39. Kurane I, Hehblewaite D, Ennis FA. Characterization with monoclonal antibodies of human lymphocytes active in natural killing and antibody-dependent cell-mediated cytotoxicity of dengue virus infected cells. Immunology 1986;58:429-36.
40. 40. Bukowski JF, Morita CT, Brenner MB. Recognition and destruction of virus-infected cells by γδ CTL. J Immunol 1994;153:5133-40.